Firefly Aerospace Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - FLY — Neutral
FLY GlobeNewsWire — November 27, 2025LOS ANGELES, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against Firefly Aerospace Inc. (“Firefly” or “the Company”) (NASDAQ: FLY) for violations of the federal securities laws. Shareholders who purchased shares of FLY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
History Says Now Is the Perfect Time to Buy Meta Stock — Positive
META The Motley Fool — November 27, 2025Investors are concerned by Meta's heavy spending. Yet, Meta's base advertising business is thriving.
Nasdaq Heads for Best Thanksgiving Week Since 2008. How Bitcoin, Tech Can Drive More Gains. — Positive
ARKB ARKW BETE BETH BITB BITC BITO BITQ BITS BITW BLKC BRRR BTCO BTCW BTF BTOP DEFI EZBC FBTC GBTC HODL IBIT SATO SPBC STCE WGMI XBTF Barrons — November 27, 2025Stocks are having their best Thanksgiving week since 2012 but as Americans around the country rush to put their turkeys in the oven even more market gains could be heating up.
Energy Transfer Is A Better Opportunity By Each Passing Quarter — Positive
ET Seeking Alpha — November 26, 2025Energy Transfer remains a top opportunity in the midstream sector, supported by strong fee-based operations and strategic partnerships. ET's Q3 earnings showed resilience, with stable core EBITDA despite commodity price weakness and a distribution increase supported by a robust coverage ratio. The Oracle and Voltagrid deal positions ET at the forefront of AI-driven energy demand, enhancing asset utilization and long-term growth prospects.
Praxis: Moving To Strong Buy Based On Ulixacaltamide Success In Treating ET — Positive
PRAX Seeking Alpha — November 26, 2025Praxis Precision Medicines, Inc. is upgraded to a Strong Buy, driven by pipeline progress and positive phase 3 data for Ulixacaltamide in Essential Tremor. PRAX's Ulixacaltamide achieved primary endpoints in two phase 3 studies, positioning it as the first potential FDA-approved therapy for Essential Tremor, targeting a large unmet market. Upcoming PRAX catalysts include a pre-NDA meeting with the FDA in Q4 2025 and a potential NDA filing for Ulixacaltamide in 2026, alongside advancing late-stage trials for Vormatrigine and Relutrigine.
This PC Maker's Stock Is Soaring on a Stronger Outlook, Thanks to AI — Positive
DELL Investopedia — November 26, 2025Dell Technologies (DELL) shares jumped Wednesday after the PC maker hiked its outlook, pointing to a boost from AI-driven demand.
Why This Health Care Stock Has Gained 35% This Week — Positive
OSCR Investopedia — November 26, 2025Shares of Oscar Health (OSCR) jumped Wednesday, the latest big gain for the health insurer after Piper Sandler analysts upgraded their rating of the stock in a recent note to clients.
Leading Independent Proxy Advisory Firm ISS Endorses All Four of Carronade's Director Nominees for Election at Cannae's Annual Meeting — Neutral
CNNE GlobeNewsWire — November 26, 2025ISS Highlights Cannae's Poor Total Shareholder Return and Operating Performance, Clear Lack of Independence from Bill Foley and Damaging Corporate Governance Deficiencies
Boeing Awarded New Apache Helicopter And Pegasus Tanker Contracts — Positive
BA Forbes — November 26, 2025A day after NASA announced it had slashed the number of astronaut missions involving the Boeing Starliner and reduced the scope of the spacecraft program, the Department of Defense awarded the aerospace giant two contracts valued at more than $7 billion.
Can Coca-Cola's Billion-Dollar Brands Power Its Next Growth Wave? — Neutral
KO Zacks Investment Research — November 26, 2025KO leverages nearly $30 billion brands, fresh innovations and global marketing to fuel its next phase of growth.
Kinross Gold: Positioned Perfectly For A Repriced Gold Market (Rating Upgrade) — Positive
KGC Seeking Alpha — November 26, 2025Kinross Gold is upgraded to Strong Buy due to even more robust free cash flow, strong financials, and attractive valuation in a fundamentally improving gold market. KGC's production remains stable, with major projects in development and a potential focus on expansion now that debt has been significantly reduced into a net cash position. Gold's fundamentals are shifting, supporting higher long-term prices, while KGC benefits from industry consolidation and limited new supply.
CPB Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Campbell's Co. — Neutral
CPB Business Wire — November 26, 2025NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of Campbell's Co. (NASDAQ: CPB) in connection with a lawsuit filed in Michigan alleging a Campbell's executive made offensive comments about Campbell's products. If you currently own shares of Campbell's stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=48524 for more information. You.
Apple Set to Top Samsung in Global Smartphone Shipments, Analyst Says — Positive
AAPL SSNLF CNET — November 26, 2025Following the launch of the iPhone 17, Apple is set to overtake Samsung phone shipments for the first time in 14 years, according to an analyst report.
Lawsuit over Burger King's Whopper ads set back by US judge — Neutral
QSR Reuters — November 26, 2025A federal judge dealt a setback to customers suing Burger King over advertising for its Whopper sandwiches, saying their claims were too disparate to justify certifying a nationwide class action.
Zillow poised for Q4 beat as house market shows signs of recovery — Positive
Z ZG Proactive Investors — November 26, 2025Zillow (NASDAQ:Z) is positioned for another quarter of outperformance in the fourth quarter as US housing momentum shows signs of strengthening, according to analysts at Jefferies. The firm repeated its ‘Buy' rating on the real estate platform with a $100 price target, implying upside of about 35% from current levels.
Alexandria Real Estate Equities, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ARE — Neutral
ARE Business Wire — November 26, 2025LOS ANGELES--(BUSINESS WIRE)--Alexandria Real Estate Equities, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ARE.
MOH DEADLINE: ROSEN, A TOP-RANKED LAW FIRM, Encourages Molina Healthcare, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 2 Deadline in Securities Class Action - MOH — Neutral
MOH Newsfile Corp — November 26, 2025New York, New York--(Newsfile Corp. - November 26, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), of the important December 2, 2025 lead plaintiff deadline. SO WHAT: If you purchased Molina securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
MOH PRNewsWire — November 26, 2025BENSALEM, Pa. , Nov. 26, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Brand Engagement Network, Inc. (BNAI) Shareholder/Analyst Call Prepared Remarks Transcript — Neutral
BNAI Seeking Alpha — November 26, 2025Brand Engagement Network, Inc. ( BNAI ) Shareholder/Analyst Call November 26, 2025 1:00 PM EST Company Participants Tyler Luck - Acting CEO, Chief Product Officer & Director James Henderson - Corporate Secretary & General Counsel Presentation Operator Good morning, and welcome to the BEN 2025 Annual Meeting of Shareholders. [Operator Instructions] I will now turn the meeting over to Tyler Luck, Acting CEO.
Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
TLX PRNewsWire — November 26, 2025LOS ANGELES , Nov. 26, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ: TLX). IF YOU SUFFERED A LOSS ON YOUR TELIX INVESTMENTS, CLICK HERE BEFORE JANUARY 9, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?